Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1360-1367

  Bours, Sandrine P G ^a,b   Van Geel, Tineke A C M ^c   Geusens, Piet P M M ^c,d   Janssen, Marcel J W ^a   Janzing, Heinrich M J ^a   Hoffland, Ge A ^a   Willems, Paul C ^b   Van Den Bergh, Joop P W ^a,b  

^a VIECURI MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHATE; TESTOSTERONE; THYROTROPIN; THYROXINE; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FINGER FRACTURE; FOOT FRACTURE; FRACTURE; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; SECONDARY OSTEOPOROSIS; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; FRACTURES, BONE; HUMANS; HYDROXYCHOLECALCIFEROLS; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; PROTEINURIA; SPINAL FRACTURES; TESTOSTERONE; THYROTROPIN; THYROXINE;

EID: 79955646419     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2135     Document Type: Article

References (32)

1. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M 2009 Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105-108
2. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A 2008 Case finding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK. Osteoporos Int 19:1395-1408
3. National Osteoporosis Foundation 2008 Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 1-36
4. Braun J, Pfeilschifter J 2010 [Osteoporosis diagnosis and therapy according to the 2010 guidelines]. Z Rheumatol 69:327-339
5. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M 2002 Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431-4437 (Pubitemid 35247019)
6. Fitzpatrick LA 2002 Secondary causes of osteoporosis. Mayo Clin Proc 77:453-468 (Pubitemid 34465153)
7. Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ, Skrabal F 2002 Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med 252:389-397 (Pubitemid 36706570)
8. Dumitrescu B, van Helden S, ten Broeke R, Nieuwenhuijzen-Kruseman A, Wyers C, Udrea G, van der Linden S, Geusens P 2008 Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach. BMC Musculoskelet Disord 9:109
9. Center JR, Bliuc D, Nguyen TV, Eisman JA 2007 Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387-394 (Pubitemid 46155800)
10. Geusens PP, Lems WF, Verhaar HJ, Leusink G, Goemaere S, Zmierczack H, Compston J 2006 Review and evaluation of the Dutch guidelines for osteoporosis. J Eval Clin Pract 12:539-548 (Pubitemid 44427286)
11. Serra-Majem L, Pfrimer K, Doreste-Alonso J, Ribas-Barba L, Sanchez-Villegas A, Ortiz-Andrellucchi A, Henriquez-Sanchez P 2009 Dietary assessment methods for intakes of iron, calcium, selenium, zinc and iodine. Br J Nutr 102(Suppl 1):S38-S55
12. World Health Organisation 2003 Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 921:1-164, back cover
13. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G 2003 National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147
14. Bilezikian JP, Potts Jr JT, Fuleihan-Gel H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353-5361 (Pubitemid 36034328)
15. Bilezikian JP, Khan AA, Potts Jr JT 2009 Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335-339
16. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC 2008 Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159:507-514
17. Buiting AM, Wijermans PW 2002 [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)]. Ned Tijdschr Geneeskd 146:1406-1411 (Pubitemid 34815066)
18. Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA 2010 Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 150:28-38
19. International Myeloma Working Group 2003 Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749-757
20. Johnson BE, Lucasey B, Robinson RG, Lukert BP 1989 Contributing diagnoses in osteoporosis. The value of a complete medical evaluation. Arch Intern Med 149:1069-1072
21. Legroux-Gérot I, Leloire O, Blanckaert F, Tonnel F, Grardel B, Ducrocq JL, Cortet B 2009 Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 76:162-165
22. González D, Sugai E, Gomez JC, Oliveri MB, Gomez Acotto C, Vega E, Bagur A, Mazure R, Mauriño E, Bai JC, Mautalen C 2002 Is it necessary to screen for celiac disease in postmenopausal osteoporotic women? Calcif Tissue Int 71:141-144
23. Becker C, Crow S, Toman J, Lipton C, McMahon DJ, Macaulay W, Siris E 2006 Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity. Osteoporos Int 17:410-416
24. Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M 2008 Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int 19:991-999
25. Vestergaard P, Mosekilde L 2003 Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. Thyroid 13:585-593 (Pubitemid 36842665)
26. Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH 2009 Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:366-372
27. Biondi B, Cooper DS 2008 The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76-131 (Pubitemid 351252748)
28. Melton 3rd LJ, Rajkumar SV, Khosla S, Achenbach SJ, Oberg AL, Kyle RA 2004 Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 19:25-30 (Pubitemid 41295134)
29. Stavroulopoulos A, Sahota O, Qamar I, Porter CJ, Cassidy MJ, Roe SD 2008 Presence of chronic kidney disease stages 3 and 4 in patients with low trauma fracture. Nephrol Dial Transplant 23:2710-2711
30. Nickolas TL, Leonard MB, Shane E 2008 Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721-731
31. Nickolas TL, McMahon DJ, Shane E 2006 Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223-3232 (Pubitemid 44707784)
32. Nitsch D, Mylne A, Roderick PJ, Smeeth L, Hubbard R, Fletcher A 2009 Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant 24:1539-1544